Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
<iframe src="https://statesidedaily.com/embed/cluster/e244aefeff6bd9498c6acd4933f057aa165e7a32" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs"></iframe>
Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
